David Campbell
Director/Board Member chez SYNAIRGEN PLC
Fortune : 21 339 $ au 31/03/2024
Profil
David Bruce Campbell is currently the Non-Executive Chairman at iQur Ltd.
and the Non-Executive Director at Synairgen Plc.
He previously held positions as Chairman at Drug Information Association, Non-Executive Director at Proximagen Group Plc, Director at Modern Biosciences Ltd., Non-Executive Director at BenevolentAI Cambridge Ltd., Scientific Director at Servier Laboratories Ltd., Senior Vice President-International Development at Neurocrine Biosciences, Inc., and Chief Scientific Officer at IP Group Plc.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
SYNAIRGEN PLC
0,16% | 31/12/2022 | 331 554 ( 0,16% ) | 21 339 $ | 31/03/2024 |
Postes actifs de David Campbell
Sociétés | Poste | Début |
---|---|---|
SYNAIRGEN PLC | Director/Board Member | 29/09/2009 |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Chairman | 01/01/2005 |
Anciens postes connus de David Campbell
Sociétés | Poste | Fin |
---|---|---|
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 29/01/2010 |
Modern Biosciences Ltd.
Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Director/Board Member | - |
Servier Laboratories Ltd.
Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Servier Laboratories Ltd. develops and manufactures pharmaceuticals. Its product portfolio includes Lonsurf, Oncaspar, Pixuvri, Valdoxan, and Natrilix. The company was founded in 1964 and is headquartered in Stoke Poges, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Chairman | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
SYNAIRGEN PLC | Health Technology |
IP GROUP PLC | Commercial Services |
Entreprise privées | 6 |
---|---|
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Modern Biosciences Ltd.
Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Health Technology |
BenevolentAI Cambridge Ltd.
BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services BenevolentAI Cambridge Ltd. develops novel small molecule therapeutics, in particular in the areas of CNS, pain and inflammation. It specializes in drug development, project management and translational medicine. The company was founded on November 26, 2003 and is headquartered in London, the United Kingdom. | Commercial Services |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Health Technology |
Servier Laboratories Ltd.
Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Servier Laboratories Ltd. develops and manufactures pharmaceuticals. Its product portfolio includes Lonsurf, Oncaspar, Pixuvri, Valdoxan, and Natrilix. The company was founded in 1964 and is headquartered in Stoke Poges, the United Kingdom. | Health Technology |